Treatment strategies and survival outcomes of primary mediastinal large B-cell lymphoma-Reference-Cited by-同舟云学术

Treatment strategies and survival outcomes of primary mediastinal large B-cell lymphoma

Published:2023-06 Issue:1 Volume:28 Page:
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Quan Lin¹,He Zhen²,Zuo Xiaoling²,Cao Lei²,Wang Yi¹,Dai Hongyu¹,Wu Wei²,Shi Xiao²,Liu Hailing²^ORCID

Affiliation:

1. Department of Respiratory Medicine, Nanjing Chest Hospital, the Affiliated Brain Hospital of Nanjing Medical University, Nanjing, People’s Republic of China

2. Department of Hematology, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, People’s Republic of China

Funder

National Natural Science Foundation of China

Science and Technology Development Fund Project

Jiangsu People’s Hospital

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/16078454.2023.2217396

Reference26 articles.

1. National Cancer Institute Surveillance Epidemiology and End Results Program. Primary mediastinal (thymic) large B-cell lymphoma. Available from: https://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd5318/

2. The molecular pathogenesis of primary mediastinal large B-cell lymphoma

3. 2016 US lymphoid malignancy statistics by World Health Organization subtypes

4. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma

5. Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relapse of primary mediastinal B-cell lymphoma with isolated central nervous system involvement: risk factors and search for personalized therapy;P.A. Herzen Journal of Oncology;2024